- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00723723
Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
February 7, 2022 updated by: Organon and Co
Compliance With LDL-Lowering Therapy For Secondary Prevention of Coronary Heart Disease in Real Life Practice
This observational study is being conducted in patients receiving statin treatment as secondary prevention of coronary heart disease under the current standard of care in compliance with European guidelines.
The purpose of the study is to evaluate the percentage of these patients that reach target LDL levels.
Additionally this study will measure the patient's compliance to treatment as assessed by counting the returned tablets.
Both assessments will be made at visits conducted 6-8 weeks after the first visit and 28-32 weeks after the first visit.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
555
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients being treated with a statin for secondary prevention of coronary heart disease
Description
Inclusion Criteria:
- willingness to participate in the study
- 18 years of age or more
- clinically established cardiovascular disease to be considered as patients in secondary prevention
- prior therapy with any statin without achieving goal (2.5 mmol/L of LDL cholesterol) at last lipid check performed
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with coronary heart disease
Patients being treated with a statin for secondary prevention of coronary heart disease
|
Statin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
percentage of patients reaching target LDL levels
Time Frame: 6-8 weeks after first visit and 28-32 weeks after first visit
|
6-8 weeks after first visit and 28-32 weeks after first visit
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
measure patient compliance to treatment as assessed by counting returned tablets
Time Frame: 6-8 weeks after first visit and 28-32 weeks after first visit
|
6-8 weeks after first visit and 28-32 weeks after first visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
July 25, 2008
First Submitted That Met QC Criteria
July 25, 2008
First Posted (Estimate)
July 29, 2008
Study Record Updates
Last Update Posted (Actual)
February 16, 2022
Last Update Submitted That Met QC Criteria
February 7, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P05467
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Boryung Pharmaceutical Co., LtdRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Ahn-Gook Pharmaceuticals Co.,LtdRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Organon and CoCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary HypercholesterolemiaChina
-
Zhejiang Hisun Pharmaceutical Co. Ltd.CompletedPrimary Hypercholesterolemia
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Unknown
-
AB Biotics, SACompletedModerate HypercholesterolemiaFrance
-
Hanmi Pharmaceutical Company LimitedCompleted
Clinical Trials on Statin
-
Antalya Training and Research HospitalCompleted
-
National Taiwan University HospitalCompletedOut-Of-Hospital Cardiac ArrestTaiwan
-
Faculty of Medicine, Tarumanagara UniversityCengkareng General HospitalCompletedAcute Coronary Syndrome | Cardiogenic Shock | Recurrent Myocardial InfarctionIndonesia
-
Taipei Medical University WanFang HospitalTerminated
-
University of Sao Paulo General HospitalUnknownAneurysmal Subarachnoid HemorrhageBrazil
-
Radboud University Medical CenterErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam...Completed
-
Translational Research Center for Medical Innovation...National Cerebral and Cardiovascular Center; Ministry of Health, Labour and... and other collaboratorsCompleted
-
National Taiwan University HospitalUnknown
-
Capital Medical UniversityRecruitingIntracerebral Hemorrhage | StatinsChina
-
University of LiverpoolUniversity of Leeds; Liverpool John Moores University; Liverpool Heart and Chest... and other collaboratorsTerminatedAtrial Fibrillation | Chronic Kidney DiseaseUnited Kingdom